2020
DOI: 10.1007/s00264-020-04782-9
|View full text |Cite
|
Sign up to set email alerts
|

Comment on an article: “Medications in COVID-19 patients: summarizing the current literature from an orthopaedic perspective”

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 8 publications
0
5
0
Order By: Relevance
“…227 It has been suggested laboratory investigation for serum tHcy and B9/B12 in all patients affected by COVID-19 during hospitalization, for potential benefits of relative supplementation of micronutrients in terms of disease severity and vascular complications. 228 However, no supporting evidence for the potential detrimental effects of hyperhomocysteinemia on bone fragility in COVID-19 patients as well as of putative benefits of its correction by B9/B12 vitamins supplementation in terms of fragility fracture prevention is available so far.…”
Section: Nutritional Issues During the Covid-19 Pandemic And Their Co...mentioning
confidence: 99%
“…227 It has been suggested laboratory investigation for serum tHcy and B9/B12 in all patients affected by COVID-19 during hospitalization, for potential benefits of relative supplementation of micronutrients in terms of disease severity and vascular complications. 228 However, no supporting evidence for the potential detrimental effects of hyperhomocysteinemia on bone fragility in COVID-19 patients as well as of putative benefits of its correction by B9/B12 vitamins supplementation in terms of fragility fracture prevention is available so far.…”
Section: Nutritional Issues During the Covid-19 Pandemic And Their Co...mentioning
confidence: 99%
“…Considering the absence of medicine specifically formulated to combat COVID-19 infection, several pharmaceutical interventions have been put into a clinical trial or implemented to symptomatically treat COVID-19 patients (Ibrahimagić et al 2020 ; Anand et al 2021a , b , c , d ). With the looming paranoia about the health risk brought about by the pandemic, self-medication among the population has increased, in the hope of preventing COVID-19 infection or relieving symptoms, they experience (Malik et al 2020 ).…”
Section: Occurrencementioning
confidence: 99%
“…6 Moreover, paracetamol has been considered the first choice analgesic and antipyretic used for COVID-19 patients considering the WHO pain management ladder. 7 Consequently, these concerns have intensified during the COVID-19 pandemic because of the exceptionally excessive purchase and domiciliary use without considering the safety measures. 8 After a paracetamol overdose, cytochrome P450 isoenzymes bioactivate the excess paracetamol to a hepatotoxic metabolite, N-acetyl-p-benzoquinoneimine (NAPQI).…”
Section: Introductionmentioning
confidence: 99%
“…The WHO urged people on March 17, 2020, with coronavirus disease 2019 (COVID-19) symptoms to avoid ibuprofen and instead utilize paracetamol . Moreover, paracetamol has been considered the first choice analgesic and antipyretic used for COVID-19 patients considering the WHO pain management ladder . Consequently, these concerns have intensified during the COVID-19 pandemic because of the exceptionally excessive purchase and domiciliary use without considering the safety measures …”
Section: Introductionmentioning
confidence: 99%